【Molecular composition】：

【CAS】：—

【source】：Cabozantinib Malate

【Certification】：

【Spec】：Malate

【DMF】：—

【use】：

Cabozantinib is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).

Cabozantinib is indicated for the treatment of patients with advanced renal cell carcinoma (RCC) who have received prior anti-angiogenic therapy.